No Detail Found!

Awareness of Leukemia among Medical Students.

Author(s)
Hira Raees Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Sidra Khan Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Halima Sadia Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Safila Naveed Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Huma Dilshad Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Sultan Ayaz Department of Eastern Medicine, Directorate of Medical Sciences, Government College University, Faisalabad, Pakistan
M Tanweer Alam Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Abstract
Objectives: The goal of current study is the assessment of awareness and knowledge about the leukemia among medical students. Background: Leukemia is a malignant disorder characterized by abnormal hematopoietic development and abandoned production of WBCS and their precursors in bone marrow and blood. It is the leading cause of death in children due to cancer. Design: A questionnaire having 14 close ended questions is given to 200 students. Data of 150 students was included in the studies while other was excluded due to incomplete information. Result: It is shown by the result that the knowledge of leukemia among medical students is 71.3%. 25.3% said leukemia is inherited, and 54% think it can acquired through blood transfusion, only 7% students know about its type, and 48.7% students think survival rate is decreasing with age. The result of statistical analysis shows significant results. Conclusion: There is a strong relationship between leukemia and Down syndrome but majority of students don't aware about this, therefore an educational program is required for medical students to improve their knowledge about leukemia.
Publication Details
Page(s) 23-26
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 4, Year: 2017

Request the full text from PASTIC

References
BlumenreichMS, 1990.The white blood cell and differential count. Clinical Methods: The History, -
HarrisonJS, 2012.,Leukemia and Lymphoma Society -
BonnetD,DickJE, 1997.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell,Nature Med 3 730 -
TefferiA,SpivakJL, 2005.Polycythemia vera: scientific advances and current practice,InSeminars in hematology 42 206 -20
RozmanC, 1995.Chronic lymphocytic leukemia,N Engl J Med 333 1052 -7
FerrandoAA,NeubergDS,StauntonJ,LohML,HuardC,RaimondiSC,BehmFG,PuiCH,DowningJR,GillilandDG,LanderES, 2002.Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia,Cancer Cell 1 75 -87
SiegelR,NaishadhamD,JemalA, 2013., 63 11 -30
JemalA,BrayF,CenterMM,FerlayJ,WardE,FormanD, 2011.,CA Cancer J Clin 61 69 -90
ChabnerBA,LongoDL, .Cancer chemotherapy and biotherapy: principles and practice,Lippincott Williams & Wilkins; 2011 Dec 7. -
BernsteinM,KovarH,PaulussenM,RandallRL,SchuckA,TeotLA,JuergensgH, 2006.Ewing's sarcoma family of tumors: current management,Oncologist 11 503 -19
TalpazM,ShahNP,KantarjianH,DonatoN,NicollJ,PaquetteR,CortesJ,O'brienS,NicaiseC,BleickardtE,Blackwood-ChirchirMA, 2006.Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias,N Engl J Med 354 2531 -41
CortesJE,KimDW,Pinilla-IbarzJL,Le CoutreP,PaquetteR,ChuahC,NicoliniFE,ApperleyJF,KhouryHJ,TalpazM,DiPersio J., 2013.A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias,N Engl J Med 369 1783 -96
2013.Treating chronic myeloid leukemia: improving management through understanding of the patient experience,Clin J Oncol Nurs 17 E13 -
MarcucciG,MrózekK,RadmacherMD,GarzonR,BloomfieldCD, 2011.The prognostic and functional role of microRNAs in acute myeloid leukemia,Blood 117 1121 -9
0

Citations

0

Downloads

97

Views